Breakthrough in Gene Therapy for Glaucoma at Trinity College Dublin
Monday, 9 September 2024, 18:30
Gene Therapy Breakthrough for Glaucoma
Scientists from Trinity College Dublin have developed a revolutionary gene therapy aimed at treating glaucoma, which is often referred to as the 'silent thief of sight'. This disease affects hundreds of thousands in Ireland and can result in irreversible vision loss.
The Importance of Early Intervention
Early diagnosis and treatment of glaucoma are crucial to preserve sight. This new gene therapy brings hope to patients and healthcare providers.
- Glaucoma affects over half a million people in Ireland.
- Genetic research is paving the way for innovative treatments.
- Continuous advancements in medical technology are essential.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.